Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Florida Weight Loss MD vs Wisp

Florida Weight Loss MD
Graded #329

Lower grade

vs+4.300000000000004
Wisp
Graded #243

Higher grade

The verdict

Wisp takes it — 64.4/100 to 60.1/100.

Wisp grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Wisp (hellowisp.com) is a US telehealth provider whose weight care vertical offers brand-name Wegovy, Zepbound, and Saxenda alongside a compounded sublingual semaglutide drops formulation at $225/month.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFlorida Weight Loss MD +1
51
50
Dose & formulationWisp +23
53
76
Clinical oversightWisp +4
78
82
Labs & monitoringFlorida Weight Loss MD +9
62
53
FulfillmentFlorida Weight Loss MD +1
67
66
Contract termsWisp +8
47
55
Florida Weight Loss MD · left barWisp · right bar

The numbers

MetricFlorida Weight Loss MDWisp
WeighScore60.1/10064.4/100
GradeCC
Scorecard rank#329#243
SemaglutideNot disclosed$225/mo (compounded oral)
TirzepatideNot disclosedNot disclosed
Coverage1 stateCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
Florida Weight Loss MD

Graded #329 · C

Strengths

  • Physician-led (Dr. Sergey Terushkin, MD, FACS) with same-day telehealth visits statewide in Florida
  • Offers both compounded GLP-1 and brand Wegovy/Ozempic/Mounjaro/Zepbound when appropriate
  • Accepts most insurance or self-pay; consult $99 with $49 applied to the program

Where it loses points

  • Florida residents only — no service outside the state
  • Monthly medication pricing is not published; disclosed after evaluation
  • Single-clinic operation rather than a national telehealth platform
Wisp

Graded #243 · C

Strengths

  • Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
  • LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
  • Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary

Where it loses points

  • The $99/mo tirzepatide figure is a consultation-and-care subscription, not the medication: Zepbound is filled at a pharmacy of your choice at its own cost, which Wisp does not publish
  • The compounded semaglutide option is sublingual drops, which Wisp itself describes as less effective than injection
  • Brand-name access is a prescription, not a dispensed product, so the drug cost is outside anything quoted here

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard